세계의 첨단 시각화 시장 : 제공별, 솔루션 유형별, 영상 모달리티별, 용도별, 최종사용자별, 지역별 - 예측(-2029년)

The global Advanced visualization market is projected to reach USD 6.55 billion by 2029 from USD 3.78 billion in 2024, at a CAGR of 11.7% during the forecast period. The market is expected to grow as a result of the increasing investments & fundings by public-private organizations, surging demand for technologically advanced visualization solutions for various applications across the industry, such as, cardiology, radiology, neurology, oncology, among others. Moreover, the market has experienced growth due to the need for improved imaging techniques across healthcare industry. However, insufficient IT infrastructure, and reluctance towards adoption of advanced visualization solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

"Cloud-based subsegment, under the advanced visualization software segment is expected to register highest growth during the forecast period."

The advanced visualization software segment is sub-segmented into on-premise and cloud-based. In 2023, the cloud-based segment is expected to register the highest growth during the forecast period. The growth of the cloud segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, the increasing demand for remote healthcare services and telemedicine solutions has accelerated the adoption of cloud technologies that facilitate easy access to imaging tools and data sharing among healthcare professionals, further contributing to the segment's growth.

"Hospitals & Ambulatory Surgical Centers is projected to dominate the market in the advanced visualization market, by end user during the forecast period."

The hospitals & ambulatory surgical centers, diagnostic & imaging centers, academic & research centers, and other end users make up the end user segments of the advanced visualization market. In 2023, the hospitals & ambulatory surgical centers accounted for a significant share of the advanced visualization market, by end user. The segment is also expected to register paramount growth during the forecast period. The prominent position & high growth of this segment is due to the increasing complexity of imaging data, demand for precise diagnostics & surgical planning, rise in minimally-invasive procedures, and the need for interoperability with existing systems. Moreover, the push for personalized medicine and precision therapeutics, the integration of AI and machine learning further strengthens the value of advanced visualization in the provider industry.

"Asia Pacific is expected to register highest market growth during the forecast period."

The advanced visualization market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register highest growth during the forecast period. The high growth of this region is attributed to the the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across healthcare industry, and significant focus on integrating sophisticated technologies across the workflows also contributes to the growth.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation - Directors: 30%, Manager: 34%, and Others: 36%
• By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report

• Agfa-Gevaert Group (Belgium)
• Canon Medical Systems Corporation (Japan)
• Fujifilm Holdings Corporation (Japan)
• GE Healthcare (US)
• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthineers AG (Germany)
• Stryker (US)
• Change Healthcare (US)
• TeraRecon (US)
• Ziosoft (Japan)
• Pro Medicus, Ltd (Australia)
• Carestream Health (US)
• Fovia, Inc. (US)
• 4DMedical (Australia)
• Synopsys, Inc. (US)
• Novarad (US)
• AnalyzeDirect, Inc. (US)
• Syntermed Inc. (Netherlands)
• Pie Medical Imaging B.V. (Netherlands)
• Infinitt Healthcare Co., Ltd. (US)
• Biotronics 3D (UK)
• Minnovaa Innovations Ou (Estonia)
• Postdicom (Netherlands)
• CitiusTech Inc (US)
• Ceevra, Inc. (US)

Research Coverage:

The report analyzes the advanced visualization market and aims to estimate the market size and future growth potential of various market segments, based on offering, solution type, imaging modality, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total advanced visualization market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (booming geriatric population, growing advancements in picture archiving and communication systems and advanced visualization, rising investments by government and private organizations, increasing need for early disease diagnosis), restraints (limited availability of reimbursements, high deployment cost of advanced visualization tools), opportunities (expanding modernization efforts in emerging economies, growing adoption of artificial intelligence and machine learning, increasing establishment of hospitals and diagnostic imaging centers), challenges (shortage of skilled personnel, declining budget allocation for health services) are factors contributing the growth of the advanced visualization market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the advanced visualization market.
• Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the advanced visualization market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global advanced visualization market such as Agfa-Gevaert Group (Belgium), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ADVANCED VISUALIZATION MARKET OVERVIEW
• 4.2 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING AND COUNTRY
• 4.3 ADVANCED VISUALIZATION MARKET, BY COUNTRY
• 4.4 ADVANCED VISUALIZATION MARKET: REGIONAL MIX
• 4.5 ADVANCED VISUALIZATION MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Booming geriatric population
    • 5.2.1.2 Growing advancements in picture archiving and communication systems and advanced visualization
    • 5.2.1.3 Rising investments by government and private organizations
    • 5.2.1.4 Increasing need for early disease diagnosis
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Limited availability of reimbursements
    • 5.2.2.2 High deployment cost of advanced visualization tools
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Expanding modernization efforts in emerging economies
    • 5.2.3.2 Growing adoption of artificial intelligence and machine learning
    • 5.2.3.3 Increasing establishment of hospitals and diagnostic imaging centers
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of skilled personnel
    • 5.2.4.2 Declining budget allocation for health services
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 INDICATIVE SELLING PRICE, BY OFFERING
  • 5.4.2 INDICATIVE SELLING PRICE, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 INVESTMENT AND FUNDING SCENARIO
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Machine learning and artificial intelligence
    • 5.8.1.2 Augmented reality and virtual reality
    • 5.8.1.3 Cloud computing
  • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.2.1 Bioinformatics tools
    • 5.8.2.2 Big data analytics
    • 5.8.2.3 Internet of things
  • 5.8.3 ADJACENT TECHNOLOGIES
    • 5.8.3.1 Blockchain
    • 5.8.3.2 Quantum computing
• 5.9 INDUSTRY TRENDS
  • 5.9.1 INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH DATA-SHARING MODALITIES
  • 5.9.2 INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH PICTURE ARCHIVING AND COMMUNICATION SYSTEMS
• 5.10 PATENT ANALYSIS
• 5.11 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.12 CASE STUDY ANALYSIS
  • 5.12.1 ENHANCED LEARNING EXPERIENCE USING ADVANCED VISUALIZATION TECHNIQUES
  • 5.12.2 IMPROVED DETERMINATION AND SIMULATION OF LYMPH NODE BY 3D RECONSTRUCTION
  • 5.12.3 ENHANCED DECISION-MAKING AND TRACKING OF TUMOR PROGRESSION WITH VISUALIZATION TOOLS
• 5.13 REGULATORY LANDSCAPE
  • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13.2 REGULATORY ANALYSIS
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 THREAT OF NEW ENTRANTS
  • 5.14.2 THREAT OF SUBSTITUTES
  • 5.14.3 BARGAINING POWER OF SUPPLIERS
  • 5.14.4 BARGAINING POWER OF BUYERS
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.15.2 BUYING CRITERIA
• 5.16 END-USER ANALYSIS
  • 5.16.1 UNMET NEEDS
  • 5.16.2 END-USER EXPECTATIONS
• 5.17 ADVANCED VISUALIZATION BUSINESS MODELS
  • 5.17.1 SUBSCRIPTION-BASED MODEL
  • 5.17.2 SAAS MODEL
  • 5.17.3 ENTERPRISE LICENSING
  • 5.17.4 FREEMIUM MODEL
  • 5.17.5 CONSULTING SERVICES MODEL
  • 5.17.6 PARTNERSHIP/REVENUE-SHARING MODEL
  • 5.17.7 HYBRID MODEL
  • 5.17.8 SERVICE MODEL
• 5.18 IMPACT OF AI/GENERATIVE AI ON ADVANCED VISUALIZATION MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 MARKET POTENTIAL OF ADVANCED VISUALIZATION
  • 5.18.3 AI USE CASES IN ADVANCED VISUALIZATION
    • 5.18.3.1 Key use cases of AI
    • 5.18.3.2 Potential use cases of gen AI
  • 5.18.4 CASE STUDY
  • 5.18.5 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.18.5.1 Diagnostic procedures
    • 5.18.5.2 Personalized treatment
    • 5.18.5.3 Predictive patient care
    • 5.18.5.4 Operational efficiency
    • 5.18.5.5 Healthcare imaging
  • 5.18.6 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.6.1 User readiness
      • 5.18.6.1.1 Hospitals & ambulatory surgical centers
      • 5.18.6.1.2 Diagnostic & imaging centers
      • 5.18.6.1.3 Academic & research centers
    • 5.18.6.2 Impact assessment
      • 5.18.6.2.1 User A: Hospitals & ambulatory surgical centers
        • 5.18.6.2.1.1 Implementation
        • 5.18.6.2.1.2 Impact
      • 5.18.6.2.2 User B: Diagnostic & imaging centers
        • 5.18.6.2.2.1 Implementation
        • 5.18.6.2.2.2 Impact
      • 5.18.6.2.3 User C: Academic & research centers
        • 5.18.6.2.3.1 Implementation
        • 5.18.6.2.3.2 Impact

6 ADVANCED VISUALIZATION MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 SERVICES
  • 6.2.1 IMPLEMENTATION SERVICES
    • 6.2.1.1 Rising installation of advanced visualization solutions in hospitals & diagnostic centers to sustain growth
  • 6.2.2 CONSULTING/OPTIMIZATION SERVICES
    • 6.2.2.1 Increasing adoption of enhanced workflow practices to support growth
  • 6.2.3 TRAINING & EDUCATION SERVICES
    • 6.2.3.1 Growing adoption of technologically advanced 3D imaging software to drive market
  • 6.2.4 POST-SALES & MAINTENANCE SERVICES
    • 6.2.4.1 Increasing availability of advanced visualization solutions to propel market
• 6.3 SOFTWARE
  • 6.3.1 ON-PREMISE SOFTWARE
    • 6.3.1.1 Rising focus on enhanced patient care and operational efficiency to augment growth
  • 6.3.2 CLOUD-BASED SOFTWARE
    • 6.3.2.1 Increasing demand for remote healthcare services and telemedicine to accelerate growth
• 6.4 HARDWARE
  • 6.4.1 GROWING DEMAND FOR HIGH-QUALITY IMAGING IN SPECIALIZED FIELDS TO BOOST MARKET

7 ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE

• 7.1 INTRODUCTION
• 7.2 ENTERPRISE-WIDE THIN CLIENT-BASED SOLUTIONS
  • 7.2.1 NEED TO IMPROVE DIAGNOSTIC CAPABILITIES ACROSS HEALTHCARE FACILITIES TO DRIVE MARKET
• 7.3 STANDALONE WORKSTATION-BASED SOLUTIONS
  • 7.3.1 INCREASING COMPLEXITY OF MEDICAL IMAGING DATA TO FACILITATE GROWTH

8 ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY

• 8.1 INTRODUCTION
• 8.2 MAGNETIC RESONANCE IMAGING
  • 8.2.1 INCREASING INSTALLATIONS OF MAGNETIC RESONANCE IMAGING MACHINES TO SUSTAIN GROWTH
• 8.3 COMPUTED TOMOGRAPHY
  • 8.3.1 RISING NEED FOR PRECISE ASSESSMENT OF COMPLEX ANATOMICAL STRUCTURES TO DRIVE MARKET
• 8.4 POSITRON EMISSION TOMOGRAPHY
  • 8.4.1 GROWING ADOPTION OF ADVANCED VISUALIZATION IN ONCOLOGY, NEUROLOGY, AND CARDIOLOGY TO BOOST MARKET
• 8.5 ULTRASOUND
  • 8.5.1 GROWING PREFERENCE OF HEALTHCARE PROFESSIONALS FOR ADVANCED ULTRASOUND TO PROPEL MARKET
• 8.6 RADIOTHERAPY
  • 8.6.1 RISING DEMAND FOR PERSONALIZED AND PRECISE CANCER TREATMENT TO PROMOTE GROWTH
• 8.7 NUCLEAR MEDICINE
  • 8.7.1 NEED TO ASSESS HEALTH AND FUNCTIONING OF CRITICAL ORGANS TO SUPPORT GROWTH
• 8.8 OTHER IMAGING MODALITIES

9 ADVANCED VISUALIZATION MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 RADIOLOGICAL/INTERVENTIONAL RADIOLOGICAL APPLICATIONS
  • 9.2.1 ONGOING TREND OF PROCESS AUTOMATION AND WORKFLOW DIGITIZATION TO AUGMENT GROWTH
• 9.3 CARDIOLOGICAL APPLICATIONS
  • 9.3.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
• 9.4 ORTHOPEDIC APPLICATIONS
  • 9.4.1 INCREASING ADVANCEMENTS IN HOLOGRAPHIC TECHNOLOGY AND VIRTUAL REALITY TO EXPEDITE GROWTH
• 9.5 ONCOLOGICAL APPLICATIONS
  • 9.5.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO SEGMENT GROWTH
• 9.6 VASCULAR APPLICATIONS
  • 9.6.1 NEED FOR PRECISE IMAGING TO SUSTAIN GROWTH
• 9.7 NEUROLOGICAL APPLICATIONS
  • 9.7.1 GROWING ADVANCEMENTS IN NEUROIMAGING TECHNIQUES TO FUEL MARKET
• 9.8 OTHER APPLICATIONS

10 ADVANCED VISUALIZATION MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS & AMBULATORY SURGICAL CENTERS
  • 10.2.1 HIGH ADOPTION RATE OF DIAGNOSTIC PROCEDURES FOR EARLY DISEASE DETECTION TO CONTRIBUTE TO GROWTH
• 10.3 DIAGNOSTIC & IMAGING CENTERS
  • 10.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO FAVOR GROWTH
• 10.4 ACADEMIC & RESEARCH CENTERS
  • 10.4.1 GROWING NUMBER OF FUNDS AND GRANTS FOR RESEARCH ACTIVITIES TO DRIVE MARKET
• 10.5 OTHER END USERS

11 ADVANCED VISUALIZATION MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Continuous technological advancements in diagnostic imaging modalities to promote growth
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing prevalence of heart ailments to expedite growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Rapid growth of diagnostic imaging research activities and outsourcing of testing to boost market
  • 11.3.3 UK
    • 11.3.3.1 Rising acceptance of advanced diagnostic imaging techniques to aid growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Easy accessibility to diagnostic assay procedures and availability of low-cost surgical facilities to spur growth
  • 11.3.5 SPAIN
    • 11.3.5.1 Increasing access to advanced cancer screening programs to stimulate growth
  • 11.3.6 ITALY
    • 11.3.6.1 Growing adoption of digitized diagnostic techniques to fuel market
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Favorable reimbursement system and growing access to healthcare systems to propel market
  • 11.4.3 CHINA
    • 11.4.3.1 Changing lifestyle and growing purchasing power to accelerate growth
  • 11.4.4 INDIA
    • 11.4.4.1 Rising trend of medical tourism to augment growth
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Free and universal public health system to contribute to market growth
  • 11.5.3 MEXICO
    • 11.5.3.1 Growing adoption of advanced devices to fuel market
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Growing focus on improving healthcare services and infrastructure to drive market
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021-DECEMBER 2024
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND/PRODUCT COMPARISON
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Application footprint
    • 12.7.5.3 Solution type footprint
    • 12.7.5.4 Imaging modality footprint
    • 12.7.5.5 Component footprint
    • 12.7.5.6 End-user footprint
    • 12.7.5.7 Region footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of key startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES AND UPGRADES
  • 12.9.2 DEALS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 AGFA-GEVAERT GROUP
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 CANON MEDICAL SYSTEMS CORPORATION
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 FUJIFILM HOLDINGS CORPORATION
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches and upgrades
      • 13.1.3.3.2 Deals
  • 13.1.4 GE HEALTHCARE
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches and upgrades
      • 13.1.4.3.2 Deals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 SIEMENS HEALTHINEERS AG
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 MnM view
      • 13.1.5.3.1 Right to win
      • 13.1.5.3.2 Strategic choices
      • 13.1.5.3.3 Weaknesses and competitive threats
  • 13.1.6 KONINKLIJKE PHILIPS N.V.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches and upgrades
      • 13.1.6.3.2 Deals
    • 13.1.6.4 MnM view
      • 13.1.6.4.1 Right to win
      • 13.1.6.4.2 Strategic choices
      • 13.1.6.4.3 Weaknesses and competitive threats
  • 13.1.7 STRYKER
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches and upgrades
      • 13.1.7.3.2 Deals
  • 13.1.8 CHANGE HEALTHCARE (UNITEDHEALTH GROUP)
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Deals
  • 13.1.9 TERARECON
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches and upgrades
      • 13.1.9.3.2 Deals
  • 13.1.10 ZIOSOFT
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches and upgrades
  • 13.1.11 PRO MEDICUS, LTD.
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Solutions/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Other Developments
  • 13.1.12 CARESTREAM HEALTH
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Solutions/Services offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product launches and upgrades
  • 13.1.13 FOVIA, INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Solutions/Services offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Deals
  • 13.1.14 4DMEDICAL
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products/Solutions/Services offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Deals
  • 13.1.15 SYNOPSYS, INC.
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products/Solutions/Services offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Deals
  • 13.1.16 NOVARAD
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products/Solutions/Services offered
  • 13.1.17 ANALYZEDIRECT, INC.
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products/Solutions/Services offered
  • 13.1.18 SYNTERMED INC.
    • 13.1.18.1 Business overview
    • 13.1.18.2 Products/Solutions/Services offered
  • 13.1.19 PIE MEDICAL IMAGING B.V.
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products/Solutions/Services offered
    • 13.1.19.3 Recent developments
      • 13.1.19.3.1 Product launches and upgrades
      • 13.1.19.3.2 Deals
  • 13.1.20 INFINITT HEALTHCARE CO., LTD.
    • 13.1.20.1 Business overview
    • 13.1.20.2 Products/Solutions/Services offered
    • 13.1.20.3 Recent developments
      • 13.1.20.3.1 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 BIOTRONICS 3D
  • 13.2.2 MINNOVAA INNOVATIONS OU
  • 13.2.3 POSTDICOM
  • 13.2.4 CITIUSTECH INC.
  • 13.2.5 CEEVRA, INC.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS